Skip to main content

Table 1 Patient demographics

From: Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study

 

Age

(years)

Sex

Education

(years)

ApoE4 carrier

Comorbidities

Medications

Case 1

58

F

6

Yes

None

Rivastigmine 18 mg, Choline alfoscerate 800 mg, Lexapro 5 mg

Case 2

80

F

9

Yes

None

Rivastigmine 18 mg, Choline alfoscerate 800 mg, Lexapro 5 mg

Case 3

55

F

12

Yes

Myasthenia gravis

Rivastigmine 27 mg, Memantine 5 mg, Lexapro 5 mg, Prednisolone 5 mg, Tacrolimus 3 mg

Case 4

85

F

12

Yes

Hypertension, osteoporosis

Donepezil 10 mg, Candesartan 16 mg, Amlodipine 5 mg, Calcium 500 mg, Cholecalciferol 1000 IU

Case 5

75

M

12

No

None

Galantamine 16 mg

Mean (SD)

70.6 (13.5)

 

10.2 (2.7)

   
  1. SD standard deviation